🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this multicentre, prospective, double blind, placebo controlled,...
Status
Completed
Location
Charité University Berlin
Start Date
2010-12-30
Trial ID
NCT01183767
Treatments Being Tested
This randomized double-blinded Phase II clinical trial will evaluate the bi...
Status
Active Not Recruiting
Location
Moffitt Cancer Center
Start Date
2020-08-21
Trial ID
NCT04300855
The investigators hypothesize that an oral Sunphenon EGCg (Epigallocatechin...
Status
Completed
Location
Charité Universitätsmedizin Berlin (NeuroCure Clinical Research Center)
Start Date
2009-05
Trial ID
NCT00799890
Treatments Being Tested
EGCG has shown a neuroprotective effect in cell-experimental and animal stu...
Status
Completed
Location
Charite University Medicine Berlin
Start Date
2009-10
Trial ID
NCT00951834
Treatments Being Tested
MSA is a rapidly progressive disorder with an average survival time of abou...
Status
Completed
Location
Neurology Department, Ludwig-Maximilians University
Start Date
2014-01
Trial ID
NCT02008721
Treatments Being Tested
The overall objective of this study is to test an intervention of green tea...
Status
Not Yet Recruiting
Location
University of Alabama at Birmingham
Start Date
2026-09-30
Trial ID
NCT07682324
Treatments Being Tested
The purpose of the study is to evaluate the efficacy and safety of green te...
Status
Completed
Location
Prince of Wales Hospital
Start Date
2016-12-08
Trial ID
NCT02832271
Treatments Being Tested
Hypothesis: Sunphenon, a green tea extract containing 95% egcg, given dail...
Status
Completed
Location
NeuroCure Clinical Research Center, Charite University, Berlin
Start Date
2007-09
Trial ID
NCT00525668
Treatments Being Tested